Mandell L - Search Results

1

A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.

Wilson R, Schentag JJ, Ball P, Mandell L; 068 Study Group. Wilson R, et al. Among authors: mandell l. Clin Ther. 2002 Apr;24(4):639-52. doi: 10.1016/s0149-2918(02)85139-6. Clin Ther. 2002. PMID: 12017408 Clinical Trial.

2

Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.

Lode H, File TM Jr, Mandell L, Ball P, Pypstra R, Thomas M; 185 Gemifloxacin Study Group. Lode H, et al. Among authors: mandell l. Clin Ther. 2002 Nov;24(11):1915-36. doi: 10.1016/s0149-2918(02)80088-1. Clin Ther. 2002. PMID: 12501883 Clinical Trial.

3

Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomised, double-blind comparison with trovafloxacin.

Ball P, Wilson R, Mandell L, Brown J, Henkel T; 069 Clinical Study Group. Ball P, et al. Among authors: mandell l. J Chemother. 2001 Jun;13(3):288-98. doi: 10.1179/joc.2001.13.3.288. J Chemother. 2001. PMID: 11450888 Clinical Trial.

4

A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.

Ball P, Mandell L, Patou G, Dankner W, Tillotson G. Ball P, et al. Among authors: mandell l. Int J Antimicrob Agents. 2004 May;23(5):421-9. doi: 10.1016/j.ijantimicag.2004.02.014. Int J Antimicrob Agents. 2004. PMID: 15120718 Review.

5

Antimicrobial safety and tolerability: differences and dilemmas.

Mandell LA, Ball P, Tillotson G. Mandell LA, et al. Clin Infect Dis. 2001 Mar 15;32 Suppl 1:S72-9. doi: 10.1086/319379. Clin Infect Dis. 2001. PMID: 11249832 Review.

6

Comparative tolerability of the newer fluoroquinolone antibacterials.

Ball P, Mandell L, Niki Y, Tillotson G. Ball P, et al. Among authors: mandell l. Drug Saf. 1999 Nov;21(5):407-21. doi: 10.2165/00002018-199921050-00005. Drug Saf. 1999. PMID: 10554054 Review.

7

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.

Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL; American Thoracic Society. Niederman MS, et al. Among authors: mandell la. Am J Respir Crit Care Med. 2001 Jun;163(7):1730-54. doi: 10.1164/ajrccm.163.7.at1010. Am J Respir Crit Care Med. 2001. PMID: 11401897 No abstract available.

8

Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.

Fogarty C, de Wet R, Mandell L, Chang J, Rangaraju M, Nusrat R. Fogarty C, et al. Among authors: mandell l. Chest. 2005 Oct;128(4):1980-8. doi: 10.1378/chest.128.4.1980. Chest. 2005. PMID: 16236845 Clinical Trial.

9

Canadian guidelines for the management of acute exacerbations of chronic bronchitis.

Balter MS, La Forge J, Low DE, Mandell L, Grossman RF; Canadian Thoracic Society; Canadian Infectious Disease Society. Balter MS, et al. Among authors: mandell l. Can Respir J. 2003 Jul-Aug;10 Suppl B:3B-32B. doi: 10.1155/2003/486285. Can Respir J. 2003. PMID: 12944998 Free article. Review.

10

Gemifloxacin: survival of the fittest.

Mandell L. Mandell L. J Antimicrob Chemother. 2000 Jul;46 Suppl T1:33-7. doi: 10.1093/oxfordjournals.jac.a020892. J Antimicrob Chemother. 2000. PMID: 10997597 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page